3-(5-((2-(benzo[d]thiazol-2-yl)hydrazono)methyl)furan-2-yl)-2-methylbenzoic acid

ID: ALA2398290

Max Phase: Preclinical

Molecular Formula: C20H15N3O3S

Molecular Weight: 377.43

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1c(C(=O)O)cccc1-c1ccc(/C=N/Nc2nc3ccccc3s2)o1

Standard InChI:  InChI=1S/C20H15N3O3S/c1-12-14(5-4-6-15(12)19(24)25)17-10-9-13(26-17)11-21-23-20-22-16-7-2-3-8-18(16)27-20/h2-11H,1H3,(H,22,23)(H,24,25)/b21-11+

Standard InChI Key:  WRYUQDYTDHZOQS-SRZZPIQSSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   -7.1181  -10.9536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -7.1169  -11.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4134  -12.1821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -6.4117  -10.5448    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.7005  -10.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.6971  -11.7732    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9131  -12.0230    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4356  -11.3542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.9218  -10.6911    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6184  -11.3494    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2139  -10.6392    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3967  -10.6344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9921   -9.9243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1830   -9.8318    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0180   -9.0314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7276   -8.6270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3289   -9.1775    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2736   -8.6944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3929   -9.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1369   -8.8364    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2180   -8.0224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.5491   -7.5456    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1957   -7.8844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8006   -9.3132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7196  -10.1263    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5453   -8.9767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3114   -9.9857    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  8 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 13  2  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 15 18  1  0
 20 24  1  0
 24 25  2  0
 24 26  1  0
 19 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2398290

    ---

Associated Targets(Human)

BCL2L2 Tchem Apoptosis regulator Bcl-W (121 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCL1 Tchem Induced myeloid leukemia cell differentiation protein Mcl-1 (3820 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCL2L1 Tchem Apoptosis regulator Bcl-X (2604 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 377.43Molecular Weight (Monoisotopic): 377.0834AlogP: 5.01#Rotatable Bonds: 5
Polar Surface Area: 87.72Molecular Species: ACIDHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.96CX Basic pKa: 3.22CX LogP: 4.95CX LogD: 2.17
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -1.82

References

1. Sleebs BE, Kersten WJ, Kulasegaram S, Nikolakopoulos G, Hatzis E, Moss RM, Parisot JP, Yang H, Czabotar PE, Fairlie WD, Lee EF, Adams JM, Chen L, van Delft MF, Lowes KN, Wei A, Huang DC, Colman PM, Street IP, Baell JB, Watson K, Lessene G..  (2013)  Discovery of potent and selective benzothiazole hydrazone inhibitors of Bcl-XL.,  56  (13): [PMID:23767404] [10.1021/jm400556w]
2. Hennessy EJ..  (2016)  Selective inhibitors of Bcl-2 and Bcl-xL: Balancing antitumor activity with on-target toxicity.,  26  (9): [PMID:26988306] [10.1016/j.bmcl.2016.03.032]

Source